Medicare coverage of CAR T therapies to require PRO data collection

In a newly issued National Coverage Determination (NCD) for CAR T therapies, CMS will require the collection of clinical and patient-reported outcome data as a condition of coverage for Medicare patients. With this coverage with evidence development (CED) requirement, CMS is aiming to identify clinical characteristics of patients who are most likely to achieve a clinical and quality of life

Read the full 603 word article

User Sign In